Variational AI at WebSummit Vancouver 2026
Read more: Variational AI at WebSummit Vancouver 2026Variational AI is excited to be joining Web Summit Vancouver 2026, one of the world’s premier technology conferences, bringing together over 20,000 attendees, investors, and innovators from across the globe… Read More about Variational AI at WebSummit Vancouver 2026
Variational AI releases Enki 4: Major update to foundation model for small- molecule drug discovery
Read more: Variational AI releases Enki 4: Major update to foundation model for small- molecule drug discoveryVariational AI introduces Enki™ 4: an improved algorithm and architecture designed to scale, expanding the pre-trained target coverage from 592 to 760 and now applicable to proximity-based therapeutics and novel… Read More about Variational AI releases Enki 4: Major update to foundation model for small- molecule drug discovery
Enamine joins Variational AI in Agora Open-Science PRMT6 Discovery Effort
Read more: Enamine joins Variational AI in Agora Open-Science PRMT6 Discovery EffortVariational AI is pleased to share that Enamine has joined the Agora Open Science Trust collaboration focused on discovering novel PRMT6 inhibitors for Spinal and Bulbar Muscular Atrophy (SBMA), a… Read More about Enamine joins Variational AI in Agora Open-Science PRMT6 Discovery Effort
AI, Drug Discovery & Startups: A Candid Talk with Handol Kim, CEO of Variational AI
Read more: AI, Drug Discovery & Startups: A Candid Talk with Handol Kim, CEO of Variational AIIn this conversation, Handol shares how his team is rethinking drug discovery using generative AI, tackling one of the most complex and high-stakes challenges in science. From a 25-year career… Read More about AI, Drug Discovery & Startups: A Candid Talk with Handol Kim, CEO of Variational AI
Variational AI to Participate in the MaRS Impact Health Summit
Read more: Variational AI to Participate in the MaRS Impact Health SummitVariational AI will participate in MaRS Impact Health, a flagship health innovation event hosted by MaRS Discovery District that brings together entrepreneurs, investors, scientists, clinicians, and policymakers working to advance… Read More about Variational AI to Participate in the MaRS Impact Health Summit
Variational AI to Participate in the Bloom Burton Healthcare Investor Conference
Read more: Variational AI to Participate in the Bloom Burton Healthcare Investor ConferenceVariational AI will participate in the Bloom Burton & Co. Healthcare Investor Conference (BBHIC), one of North America’s leading gatherings for healthcare investors and emerging life sciences companies. Meet with… Read More about Variational AI to Participate in the Bloom Burton Healthcare Investor Conference
Variational AI to speak at ALL IN Talks West
Read more: Variational AI to speak at ALL IN Talks WestVariational AI will participate in ALL IN Talks West, an event bringing together researchers, industry leaders, builders, and decision-makers focused on the practical deployment of artificial intelligence systems in real-world… Read More about Variational AI to speak at ALL IN Talks West
Variational AI to Present at PBSS Event on AI and ML in Drug Discovery
Read more: Variational AI to Present at PBSS Event on AI and ML in Drug DiscoveryVariational AI will participate in the upcoming Boston Pharmaceutical & Bioscience Society (PBSS) event, “Artificial Intelligence and Machine Learning: Shaping the Future of Therapeutic Drug Discovery, Development, and Manufacturing,” taking… Read More about Variational AI to Present at PBSS Event on AI and ML in Drug Discovery
Variational AI at BIO-Europe 2026
Read more: Variational AI at BIO-Europe 2026Variational AI will participate in BIO-Europe 2026, one of the world’s leading partnering conferences for the biotechnology and pharmaceutical industries. The event brings together biotech companies, pharmaceutical firms, investors, and… Read More about Variational AI at BIO-Europe 2026
Variational AI at Discovery on Target 2026
Read more: Variational AI at Discovery on Target 2026Variational AI will participate in Discovery on Target (DOT) 2026, a leading conference dedicated to the latest advances in drug targets and enabling technologies for therapeutic discovery. Held annually in… Read More about Variational AI at Discovery on Target 2026
